ADM’s spore-forming probiotic DE111TM receives approval from the Therapeutic Goods Administration in Australia
ADM, a global leader in innovatve solutions from nature, announced that spore-forming probiotic DE111™* (Bacillus subtilis) has received official approval from the Therapeutic Goods Administration (TGA), a part of the Australian Department of Health. This extends DE111™’s availability into new regions**, following …
>> read more








